CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
Clinical trial NCT00251888 · COMPLETED
Trial details
- NCT number
- NCT00251888
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.